Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Kidney Injury Common Following Vascular Surgery

By HospiMedica International staff writers
Posted on 05 Jan 2016
Perioperative acute kidney injury (AKI) is common in patients undergoing vascular surgery, and is associated with a high risk for cardiovascular-specific mortality, according to a new study.

Researchers at the University of Florida (Gainesville, USA) conducted a single-center study involving 3,646 patients over a period of ten years to determine the association between kidney disease and long-term cardiovascular-specific mortality following vascular surgery. More...
The main outcomes and measures of the study were perioperative AKI, presence of chronic kidney disease (CKD), and overall and cause-specific mortality. Kidney disease constituted the main covariate, after adjusting for baseline patient characteristics, surgery type, and admission hemoglobin level.

The results showed that perioperative AKI occurred in 49% of the patients, with CKD present in 14%. The top two causes of death in the study cohort were cardiovascular disease (54%) and cancer (11%). The adjusted cardiovascular mortality estimates at 10 years were 17% for patients with no kidney disease; 31% for patients with AKI without CKD; 30% for patients with CKD without AKI; and 41% for patients with both AKI and CKD. The study was published on December 23, 2015, in JAMA Surgery.

“These findings reinforce the importance of preoperative risk stratification through application of consensus staging criteria for CKD using estimated glomerular filtration rate and albuminuria for all patients undergoing major vascular surgery,” concluded lead author Azra Bihorac, MD. “Risk stratification for AKI using clinical scores and urinary biomarkers similarly can help to direct the implementation of simple and inexpensive preventive strategies in the perioperative period that could prevent or mitigate further decline in kidney function.”

AKI is an abrupt loss of kidney function that develops within 7 days and is generally caused by renal ischemia, exposure to harmful substances, an inflammatory process in the kidney, or an obstruction of the urinary tract which impedes the flow of urine. AKI may lead to a number of complications, including metabolic acidosis, high potassium levels, uremia, changes in body fluid balance, and effects on other organ systems. Those who experience AKI may have an increased risk of CKD in the future. Management includes treatment of the underlying cause and supportive care, such as renal replacement therapy.

Related Links:

University of Florida



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.